LeadIQ logo
Learn more at LeadIQ.com

Insights

Neurodegenerative Therapeutics Focus QurAlis specializes in developing precision medicines for neurodegenerative diseases like ALS and FTD, presenting a targeted sales opportunity for healthcare providers and institutions focused on neurological disorders.

Strategic Geographical Location Located in Cambridge, MA, a hub for biotechnology research and innovation, QurAlis has proximity to a network of potential partners, investors, and clients, providing a strategic advantage for sales expansions and collaborations.

Substantial Funding Backing With a total funding of $88 million and an annual revenue between $10-50 million, QurAlis showcases financial stability and growth potential, making it an attractive target for sales of services, products, or partnerships.

Competitive Positioning in Biotech Sector Ranked alongside established biotech companies like Celgene, Roche, and Genmab, QurAlis holds its ground with a focus on neurology, offering a niche sales opportunity for investors, researchers, and healthcare stakeholders looking to diversify portfolios.

Expert Harvard Affiliated Team QurAlis was founded by renowned neurodegenerative biologists from Harvard, adding credibility and expertise to its offerings, creating avenues for sales through thought leadership, scientific partnerships, and knowledge exchange within the academic and medical communities.

Similar companies to QurAlis

QurAlis Tech Stack

QurAlis uses 8 technology products and services including jQuery Migrate, jQuery, Open Graph, and more. Explore QurAlis's tech stack below.

  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Elementor
    Page Builders
  • PHP
    Programming Languages
  • X-XSS-Protection
    Security
  • Smart Slider 3
    Web Platform Extensions
  • Nginx
    Web Servers

Media & News

QurAlis's Email Address Formats

QurAlis uses at least 1 format(s):
QurAlis Email FormatsExamplePercentage
First.Last@quralis.comJohn.Doe@quralis.com
49%
First@quralis.comJohn@quralis.com
1%
First.Last@quralis.comJohn.Doe@quralis.com
49%
First@quralis.comJohn@quralis.com
1%

Frequently Asked Questions

Where is QurAlis's headquarters located?

Minus sign iconPlus sign icon
QurAlis's main headquarters is located at 100 Cambridge Park Drive 5th Floor Cambridge, MA 02140 US. The company has employees across 2 continents, including North AmericaAsia.

What is QurAlis's phone number?

Minus sign iconPlus sign icon
You can contact QurAlis's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is QurAlis's official website and social media links?

Minus sign iconPlus sign icon
QurAlis's official website is quralis.com and has social profiles on LinkedIn.

How much revenue does QurAlis generate?

Minus sign iconPlus sign icon
As of August 2024, QurAlis's annual revenue reached $15M.

What is QurAlis's SIC code NAICS code?

Minus sign iconPlus sign icon
QurAlis's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does QurAlis have currently?

Minus sign iconPlus sign icon
As of August 2024, QurAlis has approximately 79 employees across 2 continents, including North AmericaAsia. Key team members include Chief Business Officer: V. S.Chief Technology Officer: H. C.Chief Financial Officer: J. P. B.. Explore QurAlis's employee directory with LeadIQ.

What industry does QurAlis belong to?

Minus sign iconPlus sign icon
QurAlis operates in the Biotechnology Research industry.

What technology does QurAlis use?

Minus sign iconPlus sign icon
QurAlis's tech stack includes jQuery MigratejQueryOpen GraphElementorPHPX-XSS-ProtectionSmart Slider 3Nginx.

What is QurAlis's email format?

Minus sign iconPlus sign icon
QurAlis's email format typically follows the pattern of . Find more QurAlis email formats with LeadIQ.

How much funding has QurAlis raised to date?

Minus sign iconPlus sign icon
As of August 2024, QurAlis has raised $88M in funding. The last funding round occurred on Mar 09, 2023 for $88M.

When was QurAlis founded?

Minus sign iconPlus sign icon
QurAlis was founded in 2016.
QurAlis

QurAlis

Biotechnology ResearchMassachusetts, United States51-200 Employees

At QurAlis, we are neuro pioneers on a quest to cure. We work with a relentless pursuit of knowledge, a precise attention to craft, and an optimistic mindset to discover and develop effective precision medicines that have the potential to alter the trajectory of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative and neurological diseases. Founded by an internationally recognized team of neurodegenerative biologists from Harvard Medical School and Harvard University, QurAlis is advancing a pipeline with therapeutic candidates that target specific components of ALS and FTD pathology and defined patient populations based on both disease-causing genetic mutation(s) and clinical biomarkers. 

Section iconCompany Overview

Headquarters
100 Cambridge Park Drive 5th Floor Cambridge, MA 02140 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $88M

    QurAlis has raised a total of $88M of funding over 4 rounds. Their latest funding round was raised on Mar 09, 2023 in the amount of $88M.

  • $10M$50M

    QurAlis's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $88M

    QurAlis has raised a total of $88M of funding over 4 rounds. Their latest funding round was raised on Mar 09, 2023 in the amount of $88M.

  • $10M$50M

    QurAlis's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.